Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06068257 · ClinicalTrials.gov registry record
Tumor-Derived FGF19
A clinical trial of Breast Cancer and Healthy, sponsored by University of Central Florida.
- Recruiting
- Registry status
- 210
- Enrollment target
- 1
- Study location
NCT06068257 is a study of Breast Cancer and Healthy that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 210 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06068257, a study of Breast Cancer and Healthy, is actively recruiting participants, sponsored by University of Central Florida.
- RECRUITING
- Registry status
- 210 participants
- Enrollment target
- 1
- Study location
Study Summary
Identify and test thresholds, specificity and sensitivity for a potential cancer associated biomarker protein, FGF19, (and associated markers) for detection in human blood in the blood of breast and colorectal in cancer patients, and see if occurs at higher rates than healthy controls
Conditions Studied
Study Locations (1)
Florida
- Burnett School Biomedical Sciences - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2023-06-06 |
| Est. Completion | 2025-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06068257
The ClinicalTrials.gov registry entry for NCT06068257 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT06068257 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06068257 about?
NCT06068257 is a clinical study titled "Tumor-Derived FGF19". Identify and test thresholds, specificity and sensitivity for a potential cancer associated biomarker protein, FGF19, (and associated markers) for detection in human blood in the blood of breast and colorectal in cancer patients, and see if occurs at higher rates than healthy controls
What is the current status of trial NCT06068257?
This trial is currently recruiting. The enrollment target is 210 participants. The study started on 2023-06-06. Estimated completion is 2025-06.
What conditions does trial NCT06068257 study?
This clinical trial studies the following conditions: Breast Cancer, Healthy, Colorectal Cancer.
Who is sponsoring clinical trial NCT06068257?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06068257 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.